Cardioprotection: The Disconnect Between Bench and Bedside

Circulation. 2016 Aug 23;134(8):574-5. doi: 10.1161/CIRCULATIONAHA.116.022829.

Authors

Xavier Rossello¹, Derek M Yellon²

Affiliations

¹ From Hatter Cardiovascular Institute, University College London, London, UK (X.R., D.M.Y.); and NIHR UCLH Biomedical Research Centre, University College London Hospital, London, UK (D.M.Y.).
² From Hatter Cardiovascular Institute, University College London, London, UK (X.R., D.M.Y.); and NIHR UCLH Biomedical Research Centre, University College London Hospital, London, UK (D.M.Y.). d.yellon@ucl.ac.uk.

PMID: 27550967
DOI: 10.1161/CIRCULATIONAHA.116.022829

No abstract available

Keywords: cytoprotection; myocardial infarction; myocardial reperfusion injury.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Cardiotonic Agents / administration & dosage*
Humans
Myocardial Infarction / physiopathology
Myocardial Infarction / prevention & control*
Myocardial Reperfusion Injury / physiopathology
Myocardial Reperfusion Injury / prevention & control*
Point-of-Care Systems / trends*
Purinergic P2Y Receptor Antagonists / administration & dosage

Substances

Cardiotonic Agents
Purinergic P2Y Receptor Antagonists

Grants and funding

MR/K002066/1/MRC_/Medical Research Council/United Kingdom